• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Viruses . Proteomic Signatures of the Serological Response to Influenza Vaccination in a Large Human Cohort Study

tetano

Editor, Senior Moderator
Viruses


. 2022 Nov 9;14(11):2479.
doi: 10.3390/v14112479.
Proteomic Signatures of the Serological Response to Influenza Vaccination in a Large Human Cohort Study


Shaohuan Wu[SUP] 1 [/SUP], Smruti Pushalkar[SUP] 1 [/SUP], Shuvadeep Maity[SUP] 1 2 [/SUP], Matthew Pressler[SUP] 1 [/SUP], Justin Rendleman[SUP] 1 [/SUP], Burcu Vitrinel[SUP] 1 [/SUP], Michael Carlock[SUP] 3 4 [/SUP], Ted Ross[SUP] 3 4 [/SUP], Hyungwon Choi[SUP] 5 [/SUP], Christine Vogel[SUP] 1 [/SUP]



Affiliations

Abstract

The serological response to the influenza virus vaccine is highly heterogeneous for reasons that are not entirely clear. While the impact of demographic factors such as age, body mass index (BMI), sex, prior vaccination and titer levels are known to impact seroconversion, they only explain a fraction of the response. To identify signatures of the vaccine response, we analyzed 273 protein levels from 138 serum samples of influenza vaccine recipients (2019-2020 season). We found that levels of proteins functioning in cholesterol transport were positively associated with seroconversion, likely linking to the known impact of BMI. When adjusting seroconversion for the demographic factors, we identified additional, unexpected signatures: proteins regulating actin cytoskeleton dynamics were significantly elevated in participants with high adjusted seroconversion. Viral strain specific analysis showed that this trend was largely driven by the H3N2 strain. Further, we identified complex associations between adjusted seroconversion and other factors: levels of proteins of the complement system associated positively with adjusted seroconversion in younger participants, while they were associated negatively in the older population. We observed the opposite trends for proteins of high density lipoprotein remodeling, transcription, and hemostasis. In sum, careful integrative modeling can extract new signatures of seroconversion from highly variable data that suggest links between the humoral response as well as immune cell communication and migration.

Keywords: cohort analyses; influenza vaccination; seroconversion; serological response; serum proteomics.
 
Back
Top Bottom